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RESUMO
O objeƟ vo deste estudo foi comparar a quali-
dade de vida de mulheres que sobreviveram 
ao câncer de mama e de mulheres que não 
Ɵ veram a doença, e idenƟ fi car os fatores as-
sociados. Trata-se de um estudo transversal 
no qual o grupo de comparação envolve as 
sobreviventes de câncer de mama com idade 
entre 40 e 69 anos. Foram incluídas 154 mu-
lheres, 70 sobreviventes do câncer de mama 
e 84 sem a doença. O quesƟ onário SF-36 foi 
uƟ lizado para avaliar a qualidade de vida. O 
teste Qui-Quadrado e os modelos lineares 
mulƟ variados foram uƟ lizados para compa-
rar os grupos. A média esƟ mada dos compo-
nentes İ sicos e mentais foi signifi caƟ vamen-
te melhor para o grupo que sobreviveu à do-
ença (51,10 e 52,25, respecƟ vamente) quan-
do comparado ao grupo sem câncer (47,26 
e 47,93, respecƟ vamente). O estudo indicou 
que as sobreviventes do câncer de mama 
Ɵ nham melhor qualidade de vida quando 
comparadas a mulheres sem a doença.
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ABSTRACT
The objecƟ ve of this study was to com-
pare the quality of life of women who 
survived breast cancer and women who 
have not had the disease, and to idenƟ fy 
associated factors. It is cross-secƟ onal 
study in which the comparison group in-
cludes survivors of breast cancer aged be-
tween 40 and 69 years. One hundred and 
fi Ō y-four women were included, 70 with 
breast cancer and 84 without the disease. 
The SF-36 was used to evaluate quality of 
life. The chi-square test and mulƟ variate 
linear models were used to compare the 
groups. The esƟ mated mean physical and 
mental components were signifi cantly 
beƩ er for the group who survived the dis-
ease (51.10 and 52.25, respecƟ vely) com-
pared to the group without cancer (47.26 
and 47.93, respecƟ vely). The study indi-
cates that survivors of breast cancer had a 
beƩ er quality of life compared to women 
without the disease.
DESCRIPTORS
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RESUMEN
Se apuntó a comparar la calidad de vida de 
mujeres sobrevivientes al cáncer de mama 
con la de mujeres que no sufrieron la enfer-
medad, e idenƟ fi car los factores asociados. 
Estudio transversal en el que el grupo de 
comparación envuelve a las sobrevivientes 
de cáncer de mama con entre 40 y 69 años. 
Fueron incluidas 154 mujeres, 70 sobrevivi-
entes del cáncer de mama y 84 no afectadas. 
El cuesƟ onario SF-36 fue uƟ lizado para eval-
uar la calidad de vida. El test Chi-cuadrado 
y los modelos lineales mulƟ variados fueron 
uƟ lizados en la comparación de los grupos. 
La media esƟ mada de los componentes İ si-
cos y mentales fue signifi caƟ vamente mejor 
para el grupo que sobrevivió a la enfermedad 
(51,10 y 52,25, respecƟ vamente), en com-
paración al grupo sin cáncer (47,26 y 47,93, 
respecƟ vamente). El estudio indicó que las 
sobrevivientes al cáncer de mama tenían me-
jor calidad de vida comparadas con aquellas 
que no padecieron la enfermedad.
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INTRODUCTION
Breast cancer (BC) is the most common malignancy 
among women, comprising 22% of all cases worldwide(1). It 
has been reported that over one million women are diagno-
sed annually(2). With the development of techniques for early 
diagnosis and more eﬀ ecƟ ve treatment, the number of can-
cer survivors in the long term has grown exponenƟ ally over 
the past 20 years(3). The most recent survivorship data from 
the NaƟ onal Cancer InsƟ tute indicate there are over 11.4 
million North American cancer survivors, and that 23% of all 
cancer survivors in that country are BC survivors(4).
Over the last two decades, could be observed reduc-
Ɵ on in rates of mortality from breast cancer and cervix 
in countries of Europe and North America(5-6). However, 
the situaƟ on has been diﬀ erent in developing countries. 
In LaƟ n America, BC mortality has increased, and cervi-
cal cancer, although declining mortality in 
some countries, it is sƟ ll responsible for 
expressive number of deaths in women(7). 
In Brazil, studies, of trend of mortality from 
BC and cervix are concentrated in capital 
ciƟ es or States of the FederaƟ on, being 
liƩ le known mortality profi le these causes 
in midsized ciƟ es(8-11). Recently, it was de-
monstrated that BC was the main cause 
of cancer-related death for women in Juiz 
de Fora, Brazil. Trend analysis using the 
polynomial regression model showed a de-
crease in mortality due to uterine cervical 
cancer (p = 0.001) and an increase in mor-
tality due to breast cancer (p = 0.035) over 
the course of the Ɵ me series(12).
With this rise in survival rates, the inte-
rest of researchers and health professionals 
has greatly increased concerning the impact 
of chronic diseases, parƟ cularly cancer, and 
their treatments on the quality of life (QOL) 
of these survivors(13). Several studies linking BC and QOL 
have shown that the diagnosis and treatments can have 
social, physical, emoƟ onal and psychological repercus-
sions which aﬀ ect women with breast cancer, which may 
contribute to a wide variety of side eﬀ ects that are closely 
related to poor QOL outcomes(14-16). Nevertheless, other 
studies which have assessed QOL in women with BC in 
diﬀ erent socio-cultural contexts have shown that as the 
years pass, the QOL of women with BC becomes compa-
rable to that of women without BC(17-18). Notes that there 
are few studies assessing the QOL in Brazilian women BC 
survivors(19).
Considering that sociodemographic and clinical diﬀ e-
rences may infl uence QOL, this study aims to compare the 
QOL of Brazilian women who have survived BC with that 
of women without BC.
METHOD
A cross-secƟ onal study was carried out with one group 
of BC survivors and one group without cancer for compa-
rison. It included 154 women, 70 with breast cancer and 
84 without cancer. BC group was selected from private 
(49 women) and public services (21 women) in the North 
of Minas Gerais (Brazil). The parƟ cipants without cancer 
were selected from among teaching staﬀ , public servants, 
housewives and autonomous women. Inclusion criteria 
for BC group: age 40-69 years, not currently undergoing 
any cancer treatment for at least a year, and without his-
tory of other malignant tumors. Inclusion criteria for con-
trol group: age 40-69 years, without history of cancer.
All parƟ cipants were interviewed in order to assess their 
socio-demographic and clinical features such as age, parity, 
marital status, ethnicity and age at menarche. Clinical charac-
terisƟ cs of the BC group included tumor stage, 
histopathological type, whether they had che-
motherapy or radiaƟ on therapy, type of sur-
gery, and the Ɵ me elapsed since BC diagnosis.
Clinical and socio-demographic characte-
risƟ cs were compared between the groups. 
QOL was assessed using the Medical Outco-
mes Study 36-item Short-Form Health Sur-
vey (SF-36) quesƟ onnaire, a generic tool for 
evaluaƟ ng QOL(20), with eight components 
condensed into two summaries: a physical 
component summary (PCS) and a mental com-
ponent summary (MCS). The quesƟ onnaires 
were administered by one of the invesƟ gators 
through interviews. Data were transferred to 
SPSS® 17.0. Women without cancer and with 
BC were compared using the chi-square test. 
Measurements were performed to describe 
the eight dimensions of the SF-36 as well as 
summarising physical and mental components 
through univariate analysis. MulƟ variate ge-
neralised linear models were used in order to 
analyse data. These staƟ sƟ cal models were used to idenƟ fy 
the factors that had aﬀ ected the subjects’ QOL, with adjust-
ments made for confounding variables. A p-value of 0.05 was 
considered staƟ sƟ cally signifi cant. The study was approved 
by the Research Ethics Board of the University. Each inter-
viewee signed an informed consent form before the inter-
view (# 1957/2010).
RESULTS
Table 1 presents socio-demographic and clinical fe-
atures of the 154 participants. In the BC group, stage 
II was more frequently found (55.7%). Mastectomies 
had been performed on 55.7%. 44.3% had undergone 
breast conservation therapy and 18.6% of these wo-
men had postmastectomy breast reconstruction. Most 
of the group had undergone chemotherapy (81.4%). It 
Several studies 
linking BC and 
QOL have shown 
that the diagnosis 
and treatments 
can have social, 
physical, emotional 
and psychological 
repercussions which 
affect women with 
breast cancer, which 
may contribute to a 
wide variety of side 
effects that are closely 
related to poor QOL 
outcomes.
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was observed that more than 75.0% of this group had 
been diagnosed at least five years beforehand. The QOL 
scores are shown in Table 2. The highest QOL scores 
among women who had survived BC were observed in 
terms of physical functioning components (82.9) and 
social functioning (87.7), while role-physical (69.9) and 
vitality (73.9) scored the lowest. The highest QOL sco-
res among women without cancer were found in terms 
of physical functioning components (79.8) and social 
functioning (73.7), while role-physical (56.5) and vitali-
ty (62.6) scored the lowest. Mean PCS and MCS scores 
were 50.3 and 53.9, respectively for women with BC; 
for the women without cancer, these scores were 47.6 
and 47.9, respectively.
Table 1 - The socio-demographic and clinical characteristics of BC survivors and women without cancer - Montes Claros, MG, 
Brazil, 2011
Characteristics
With breast cancer Without breast cancer
*p-value
N % N %
Age (years)
40-49 20 28.6 39 46.4
0.00450-59 27 38.6 35 41.7
60-69 23 32.9 10 11.9
Ethnicity
White 58 82.9 28 33.3
0.000
Non white 12 17.1 56 66.7
Marital status
Married/living with partner   56 80.0 49 58.3
0.007
Single/separated/widow 14 20.0 35 41.7
Menopausal status
Pre-menopause 9 12.9 43 51.2
0.000
Post-menopause 61 87.1 41 48.8
Tumor Stage 
0/I 19 27.1
II 39 55.7
III/IV 12 17.1
Type of surgery
Mastectomy 39 55.7
Breast-conservation therapy 31 44.3
Chemotherapy
Yes 57 81.4
No 13 18.6
Radiotherapy
Yes 69 98.6
No 1 1.4
Time since diagnosis (years)
≥ 1 and <2     2   2.8
≥ 2 and <5 15 21.4
≥  5 53 75.8
Total 70 100 84 100
* chi-square test
Note: (n=70) and (n=84)
Table 3 shows that a mulƟ variate general linear model 
analysis of PCS and MCS scales was performed. It was ne-
cessary to adjust the groups with and without BC because 
they were not comparable due to the variables of age, eth-
nicity, marital and menopausal status. We observed there 
was a signifi cant diﬀ erence between the groups with and 
without BC regarding PCS (p=0.009) and MCS (p=0.022), 
in favor of BC survivors. The best PCS (β=3.51) and MCS 
(β=4.32) scores were for the group of BC survivors. Mean 
esƟ mated PCS scores was signifi cantly beƩ er for the group 
with BC (51.1) compared to those without cancer (47.56). 
When comparing MCS scores of both groups, they were di-
ﬀ erent again, revealing a mean of 52.25 for women with BC 
and 47.93 for women without cancer. Considering only the 
BC survivors (Table 4), we observed that marital status was 
signifi cant (p=0.019) between the groups, and the mean es-
Ɵ mated MCS scores for the groups without a partner and 
with a partner were 39.00 and 43.77, respecƟ vely.
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Table 2 - Univariate analysis of all SF-36 dimensions of women with breast cancer and without breast cancer - Montes Claros, MG, 
Brazil, 2011
Dimensions 
With breast cancer Without breast cancer
Mean 
(SD)
95%  
(CI) Median Min Max
Mean 
(SD)
95%
(CI) Median Min Max
Physical 
functioning
82.9 
(16.6) 78.9-86.9 88.5 0 98.5
79.8 
(22.3) 74.9-84.6 88.5 18.5 98.5
Role-physical 69.9 (22.7) 64.2-75.1 80.0 5.0 80.0
56.5 
(31.4) 49.7-63.3 80.0 5.0 80.0
Body pain 79.2 (17.5) 75.0-83.4 82.8 29.8 98.8
67.8 
(23.9) 62.6-73.0 70.8 20.8 98.8
General health 79.8 (12.3) 76.9-82.7 80.8 28.8 93.8
65.6 
(17.0) 61.9-69.3 69.7 23.8 90.8
Vitality 73.9 (14.4) 70.5-77.4 73.8 23.8 98.8
62.6 
(17.3) 58.8-66.3 63.8 23.8 98.8
Social 
functioning
87.7 
(15.9) 83.9-91.5 98.7 23.8 98.8
73.7 
(20.9) 69.2-78.3 73.8 11.3 98.8
Role-emotional 77.6 (37.0) 68.8-86.5 100.0 0 100.0
71.4 
(39.1) 62.9-79.9 100.0 0 100.0
Mental health 77.6 (16.0) 73.8-81.4 82.0 16.0 100.0
67.6 
(17.5) 63.8-71.4 68.0 16.0 96.0
PCS 50.3  (4.8) 49.1-51.4 51.4 35.3 57.6 47.6 (7.9) 45.9-49.3 49.4 18.8 61.1
MCS 53.9  (8.6) 51.9-56.0 56.6 23.6 67.0 47.9 (9.8) 45.8-50.0 48.5 20.4 63.7
PCS=physical component summary; MCS=mental component summary; SD=standard deviation; CI=confi dence interval
Table 3 - Scales adjusted according to the socio-demographic and clinical characteristics of the women with breast cancer and without 
breast cancer -  Montes Claros, MG, Brazil, 2011
Parameter
PCS
Mean (SE)
MCS
Mean (SE)
estimate β (SE) p-value estimate β (SE) p-value
Interceptor 47.10 (1.84) 0.000 45.29 (2.62) 0.000
Group
With breast cancer 3.51 (1.32) 0.009 51.10 (1.09) 4.32 (1.87) 0.022 52.25 (1.54)
Without breast cancer ref. 47.56 (0.81) ref. 47.93(1.15)
Age
40-49 2.23(1.93) 0.249 -0.22 (2.72) 0.935
50-59 1.25 (1.46) 0.392 -0.08  (2.06) 0.970
60-69 ref. ref.
Ethnicity
White 1.26 (1.25) 0.314 1.53 (1.76) 0.385
Non white ref. ref.
Marital status
Single/widow/separated 2.07 (1.19) 0.085 -4.02 (1.68) 0.018
Married/living with partner ref. ref.
Menopausal status
Pre-menopause 1.57 (1.84) 0.395 0.08 (2.60) 0.977
Post-menopause ref. ref.
ref=reference category for comparisons; β= estimated coeffi cient; SE=standard error
Note: (n=70) and (n=84)
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DISCUSSION
BC promotes physical, social and emoƟ onal changes in 
the lives of these women. The measurement of the QOL 
can determine the impact of the disease and the treat-
ment promotes these life allowing paƟ ents able to miƟ ga-
te these alternaƟ ves make clear changes compared with 
women without cancer(19). These impacts are mostly ne-
gaƟ ve and are present in all periods and even aŌ er tre-
atment for follow up(21). Our main objecƟ ve was to com-
pare the QOL of female BC survivors with that of women 
without cancer, using the SF-36 survey. Several previous 
studies have used the SF-36 to study the QOL of BC pa-
Ɵ ents(17,22). In our study, we observed that when analyzing 
all the dimensions of the SF-36 in women with and wi-
thout BC, physical funcƟ oning and social funcƟ oning had 
the best scores in both groups. These fi ndings are consis-
tent with those of previously published studies on diﬀ e-
rent populaƟ ons of BC survivors(22-23), which emphasized 
the importance of psychological support and physical the-
rapy in reducing the need for further cancer treatment(24). 
Meanwhile, vitality scored lowest in both groups in our 
study. This was also confi rmed by another study(23).
When we carried out the mulƟ variate-adjusted analy-
ses, comparing both groups, PCS and MCS scores were 
signifi cantly beƩ er for the BC survivors compared with the 
control group, with mean PCS and MCS scores of 51 and 
52, respecƟ vely for the cancer group. The mean PCS and 
MCS scores observed(17) were 50, which is a similar result 
to our fi ndings, indicaƟ ng good QOL scores. Another stu-
dy(25) has also recorded good QOL scores for German wo-
men with BC, reporƟ ng a global health score that was si-
milar to that of the general populaƟ on. We observed that 
age showed no associaƟ on with QOL. However, previous 
studies have idenƟ fi ed age as a predictor of QOL(17,26).
There is evidence that women who are saƟ sfi ed with 
their partners report feeling beƩ er psychologically(15). In 
our mulƟ variate-adjusted analysis, BC survivors living wi-
thout partners had a worse QOL (with a mean MCS score 
of 39.0 versus 43.7 for those living with a partner). This 
fi nding is in accordance with a study that has shown that 
BC survivors who had a partner had reported a beƩ er 
QOL(27). Other study(28) reported that the mean scores for 
QOL showed that women who were married or lived with 
a partner demonstrated beƩ er general health and well-
being. On the other hand, found no associaƟ on between 
QOL and marital status(17).
The relaƟ onship between adjuvant chemotherapy 
and QOL was examined, and we observed no staƟ sƟ cally 
signifi cant diﬀ erence between the groups regarding glo-
bal QOL. These fi ndings are in accordance with a study 
from Korea(29). However, in a large longitudinal study(17), 
reported poor QOL for women who had received syste-
mic adjuvant therapy. These fi ndings suggest the eﬀ ects 
of adjuvant therapy persist many years aŌ er chemothera-
py compleƟ on. There is controversy in relevant literature 
over whether the type of surgery received is related to 
QOL(30-31). It was observed during a QOL study(32) using SF-
36, recruited 75 Brazilian female BC survivors and found 
that, aŌ er mulƟ variate analysis, breast conservaƟ on the-
rapy was negaƟ vely correlated with physical aspects of 
QOL. In this study, the type of surgery had no impact on 
the global QOL. We have speculated these results might 
refl ect a homogeneous division between the groups in the 
number of mastectomies (n=39) and of breast conserva-
Ɵ on therapy (n=31).
Table 4 - Scales adjusted according to the socio-demographic and clinical characteristics of women with breast cancer - Montes Claros, 
MG, Brazil, 2011
Parameter
PCS
Mean (SE)
MCS
Mean (SE)
estimate β (SE) p-value estimate β (SE) p-value
Interceptor 50.02 (3.63) 0.000 40.22 (5.72) 0.000
Age
40-49 0.91 (1.69) 0.594 50.99 (2.60) -0.71 (2.67) 0.790 40.96 (4.09)
50-59 -1.35 (1.54) 0.383 48.73 (2.29) -1.63 (2.43) 0.504 40.04 (3.60)
60-69 ref. 50,08 (2,17) ref. 41,67 (3.42)
Chemotherapy
Yes 0.45 (1.68) 0.791 49.71 (2.13) -1.04 (2.65) 0.697 40.37 (3.36)
No ref. 50.16 (2.51) ref. 41.41 (3.96)
Type of surgery
Mastectomy 0.91 (1.24) 0.468 50.39 (2.23) 2.95 (1.96) 0.137 42.36 (3.52)
Breast conservation therapy ref. 49.48 (2.29) ref. 39.42 (3.61)
Marital status
Single/separated/widow 1.06 (1.52) 0.488 50.46 (2.38) -5.77 (2.40) 0.019 39.00 (3.75)
Married/living with partner ref. 49.40 (2.22) ref. 43.77 (3.51)
ref=reference category for comparisons; β=estimated coeffi cient; SE=standard error
Note: (n=70)
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